Spyre Therapeutics Inc. XNAS: SYRE

Download real time

15.35 0.30 (1.99%)

61.87% Fall from 52W High

45,993

XNAS Volume

XNAS 18 Sep, 2025 10:11 AM (EDT)

Spyre Therapeutics Inc. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents